喻红英;向娟;林晓春;李庆德;郑锦坤;
YU Hongying;XIANG Juan;LIN Xiaochun;LI Qingde;ZHENG Jinkun;Yue Bei People's Hospital;Jishou University;

• 1:粤北人民医院
• 2:吉首大学

摘要(Abstract)：

目的探讨离子凝胶法制备壳聚糖纳米粒(CS-NPs)的影响因素。方法用碱降解法制备高脱乙酰度的壳聚糖(CS),并以之为材料,采用离子凝胶法制备CS-NPs,以微粒的平均粒径、分散度和Zeta电位为指标,考察CS及三聚磷酸钠(TPP)的质量浓度、CS/TPP质量比、CS溶液p H值和CS溶液温度对制备CS-NPs的影响。并用透射电子显微镜观察纳米粒的形态。结果 CS-NPs的平均粒径随CS、TPP质量浓度及CS/TPP质量比的增大而增大,CS/TPP质量比的增加、CS溶液p H值的降低可引起CS-NPs的Zeta电位增高,CS溶液p H值和温度对CS-NPs的分散度影响较大;制备的壳聚糖纳米粒形态较为规则,类似球形。结论 CS及TPP的质量浓度、质量比、CS溶液p H值是制备壳聚糖纳米粒并影响其特征的主要因素。
OBJECTIVE To explore the factors for the preparation of chitosan nanoparticles( CS-NPs) by ionic gelation technique. METHODS Highly deacetylated chitosan( CS) were prepared by alkaline degradation,land were used as materials to prepare CS-NPs by ionic gelation technique. Variations in CS mass concentration,sodium tripolyphosphate( TPP) mass concentration,CS to TPP mass ratio,pH value and temperature of CS solution were examined systematically for their effects on the perparatiopn of CS-NPs by using nanoparticle size,dispersion and zeta potential as indexes. Besides,the morphology of nanoparticle was observed by transmission electron microscope. RESULTS The nanoparticle average size was increased by increasing of CS mass concentration,TPP mass concentration and CS/TPP mass ratio. When CS to TPP mass ratio increased and pH value of CS solution decreased,zeta potential increased. The pH value and temperature of CS solution had great influence on the dispersion of CS-NPs. Chitosan nanoparticles had a regular shape quite like a sphere. CONCLUSION CS mass concentration,TPP mass concentration,CS/TPP mass ratio and p H value of CS are the main factors influencing the preparation and characteristics of CS-NPs.

关键词(KeyWords)： 壳聚糖;纳米粒;离子凝胶法;影响因素
chitosan;nanoparticles;ionic gelation;influencing factors

Abstract:

Keywords:

基金项目(Foundation): 韶关市卫生计生科研计划项目(Y19050)

作者(Author): 喻红英;向娟;林晓春;李庆德;郑锦坤;
YU Hongying;XIANG Juan;LIN Xiaochun;LI Qingde;ZHENG Jinkun;Yue Bei People's Hospital;Jishou University;

Email:

DOI:

参考文献(References)：

• [1]赖坤平．甲壳素和壳聚糖在医药领域的应用[J]．今日药学，2009,19(11)∶14-16．
• [2]Matalqah S M,Aiedeh K,Mhaidat N M,et al.Chitosan nanoparticles as a novel drug delivery system:A review article[J].Curr Drug Targets,2020,21(15)∶1613-1624．
• [3]Sharma M,Sharma R,Jain D K,et al.Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles:Optimization and pharmacokinetic study[J].Int J Biol Macromol,2019,135:246-260．
• [4]王霞辉，杨博文，许潇文，等．壳聚糖季铵盐对镁铝氢氧化物所载药物稳定作用的研究[J]．华西药学杂志，2019,34(6):569-572．
• [5]Islam N,Ferro V.Recent advances in chitosan-based nanoparticulate pulmonary drug delivery[J].Nanoscale,2016,8(30)∶14341-14358．
• [6]He C B,Hu Y P,Yin L C,et al.Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles[J].Biomaterials,2010,31(13):3657-3666．
• [7]李凤生，罗付生．可生物降解药物载体:纳米/亚微米壳聚糖微球的制备及性能[J]．精细化工，2003,20(4)∶197-200．
• [8]何文，匡长春，张洪，等．壳聚糖的分子参数对载药壳聚糖纳米粒体外性质的影响研究[J]．中国药学杂志，2005,40(6):438-440．
• [9]刘小芳，吴仪君，石玮玮，等．叶酸壳聚糖姜黄素p H敏感脂质体的制备及靶向性研究[J]．中国新药杂志，2018,27(19):2315-2321．
• [10]Csaba N,K9ping-H9ggrd M,Alonso M J.Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery[J].Int J Pharm,2009,382(1-2):205-214．
• [11]Malhotra M,Lane C,Tomaro-Duchesneau C,et al.A novel method for synthesizing PEGylated chitosan nanoparticles:Strategy,preparation,and in vitro analysis[J].Int J Nanomedicine,2011,6:485-494．
• [12]聂莉，吴晓芳，伊萍，等．壳聚糖中脱乙酰度测定方法的探讨[J]．中国卫生检验杂志，2005,15(3):328-329．
• [13]Mao S,Sun W,Kissel T.Chitosan-based formulations for delivery of DNA and siRNA[J].Adv Drug Deliv Rev,2010,62(1)∶12-27．
• [14]Babii O,Wang Z G,Liu G Y,et al.Low molecular weight chitosan nanoparticles for Cp G oligodeoxynucleotides delivery:Impact of molecular weight,degree of deacetylation,and mannosylation on intracellular uptake and cytokine induction[J].Int J Biol Macromol,2020,159:46-56．
• [15]Gan Q,Wang T,Cochrane C,et al.Modulation of surface charge,particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery[J].Colloids Surfaces B:Biointerfaces,2005,44(2-3):65-73.